147 related articles for article (PubMed ID: 10688602)
1. 6-NO(2)-norepinephrine increases norepinephrine release and inhibits norepinephrine uptake in rat spinal synaptosomes.
Li X; Rose G; Chiari A; Pan HL; Tobin JR; Eisenach JC
J Pharmacol Exp Ther; 2000 Mar; 292(3):895-9. PubMed ID: 10688602
[TBL] [Abstract][Full Text] [Related]
2. S-nitroso-l-cysteine releases norepinephrine in rat spinal synaptosomes.
Li X; Rose G; Dongre N; Pan HL; Tobin JR; Eisenach JC
Brain Res; 2000 Jul; 872(1-2):301-7. PubMed ID: 10924712
[TBL] [Abstract][Full Text] [Related]
3. Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord.
Sweeney MI; White TD; Sawynok J
J Pharmacol Exp Ther; 1989 Jan; 248(1):447-54. PubMed ID: 2492344
[TBL] [Abstract][Full Text] [Related]
4. Characterization of nitric oxide generator-induced hippocampal [3H]norepinephrine release. II. The role of calcium, reverse norepinephrine transport and cyclic 3',5'-guanosine monophosphate.
Lonart G; Johnson KM
J Pharmacol Exp Ther; 1995 Oct; 275(1):14-22. PubMed ID: 7562542
[TBL] [Abstract][Full Text] [Related]
5. Spinal norepinephrine release from nitric oxide species is not increased following peripheral nerve injury in rats.
Zhu X; Li X; Eisenach JC
Brain Res; 2002 Aug; 947(2):199-203. PubMed ID: 12176161
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine release from spinal synaptosomes: auto-alpha2 -adrenergic receptor modulation.
Li X; Zhao Z; Pan HL; Eisenach JC; Paqueron X
Anesthesiology; 2000 Jul; 93(1):164-72. PubMed ID: 10861160
[TBL] [Abstract][Full Text] [Related]
7. alpha2A-adrenoceptor stimulation reduces capsaicin-induced glutamate release from spinal cord synaptosomes.
Li X; Eisenach JC
J Pharmacol Exp Ther; 2001 Dec; 299(3):939-44. PubMed ID: 11714880
[TBL] [Abstract][Full Text] [Related]
8. Hyposmolarity evokes norepinephrine efflux from synaptosomes by a depolarization- and Ca2+ -dependent exocytotic mechanism.
Tuz K; Pasantes-Morales H
Eur J Neurosci; 2005 Oct; 22(7):1636-42. PubMed ID: 16197504
[TBL] [Abstract][Full Text] [Related]
9. KCl stimulation increases norepinephrine transporter function in PC12 cells.
Mandela P; Ordway GA
J Neurochem; 2006 Sep; 98(5):1521-30. PubMed ID: 16879714
[TBL] [Abstract][Full Text] [Related]
10. Activation of gamma-aminobutyric acid GAT-1 transporters on glutamatergic terminals of mouse spinal cord mediates glutamate release through anion channels and by transporter reversal.
Raiteri L; Stigliani S; Patti L; Usai C; Bucci G; Diaspro A; Raiteri M; Bonanno G
J Neurosci Res; 2005 May; 80(3):424-33. PubMed ID: 15789377
[TBL] [Abstract][Full Text] [Related]
11. Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline.
Sweeney MI; White TD; Sawynok J
J Pharmacol Exp Ther; 1987 Nov; 243(2):657-65. PubMed ID: 2824755
[TBL] [Abstract][Full Text] [Related]
12. Alcohol-membrane interaction in the brain: norepinephrine release.
Sun AY
Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):705-19. PubMed ID: 1005916
[TBL] [Abstract][Full Text] [Related]
13. Agmatine transport into spinal nerve terminals is modulated by polyamine analogs.
Goracke-Postle CJ; Overland AC; Stone LS; Fairbanks CA
J Neurochem; 2007 Jan; 100(1):132-41. PubMed ID: 17227436
[TBL] [Abstract][Full Text] [Related]
14. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic acetylcholine receptor regulation of spinal norepinephrine release.
Li X; Eisenach JC
Anesthesiology; 2002 Jun; 96(6):1450-6. PubMed ID: 12170059
[TBL] [Abstract][Full Text] [Related]
16. Formation of 6-nitro-norepinephrine from nitric oxide and norepinephrine in the spinal cord and its role in spinal analgesia.
Chiari A; Li XH; Xu Z; Pan HL; Eisenach JC
Neuroscience; 2000; 101(1):189-96. PubMed ID: 11068147
[TBL] [Abstract][Full Text] [Related]
17. Involvement of intracellular Ca2+ stores in 3,4-diaminopyridine-evoked [3H]norepinephrine release.
Huang HY; Zhou CW
Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):302-5. PubMed ID: 9812707
[TBL] [Abstract][Full Text] [Related]
18. The human immunodeficiency virus-1 protein transactivator of transcription up-regulates N-methyl-D-aspartate receptor function by acting at metabotropic glutamate receptor 1 receptors coexisting on human and rat brain noradrenergic neurones.
Longordo F; Feligioni M; Chiaramonte G; Sbaffi PF; Raiteri M; Pittaluga A
J Pharmacol Exp Ther; 2006 Jun; 317(3):1097-105. PubMed ID: 16489129
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.
Rothman RB; Baumann MH; Dersch CM; Romero DV; Rice KC; Carroll FI; Partilla JS
Synapse; 2001 Jan; 39(1):32-41. PubMed ID: 11071707
[TBL] [Abstract][Full Text] [Related]
20. Multiple cellular mechanisms mediate the effect of lobeline on the release of norepinephrine.
Sántha E; Sperlágh B; Zelles T; Zsilla G; Tóth PT; Lendvai B; Baranyi M; Vizi ES
J Pharmacol Exp Ther; 2000 Jul; 294(1):302-7. PubMed ID: 10871326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
